HLB Genex, Inc. (KOSDAQ:187420)
South Korea · Delayed Price · Currency is KRW 2,710.00
-70.00 (-2.52%)
At close: Jan 21, 2026
HLB Genex Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 40,950 | 35,430 | 27,008 | 27,802 | 25,874 | 18,769 |
| 40,950 | 35,430 | 27,008 | 27,802 | 25,874 | 18,769 | |
Revenue Growth (YoY) | 17.56% | 31.18% | -2.85% | 7.45% | 37.85% | 25.62% |
Cost of Revenue | 25,432 | 21,129 | 19,677 | 17,586 | 16,043 | 12,711 |
Gross Profit | 15,518 | 14,301 | 7,331 | 10,215 | 9,831 | 6,059 |
Selling, General & Admin | 5,787 | 4,545 | 4,037 | 4,130 | 2,919 | 2,334 |
Research & Development | 7,936 | 10,271 | 11,608 | 11,681 | 10,413 | 8,025 |
Amortization of Goodwill & Intangibles | 41.49 | 44.52 | 44.81 | 44.5 | 42.49 | 42.73 |
Other Operating Expenses | 324.03 | 324.03 | 643.1 | 70.84 | 68.78 | 89.49 |
Operating Expenses | 15,039 | 16,147 | 16,795 | 16,440 | 13,665 | 10,757 |
Operating Income | 479.33 | -1,846 | -9,464 | -6,224 | -3,834 | -4,698 |
Interest Expense | -9,217 | -4,257 | -5,506 | -6,328 | -3,963 | -2,091 |
Interest & Investment Income | 1,217 | 521.64 | 1,090 | 1,009 | 431.41 | 226.95 |
Currency Exchange Gain (Loss) | 576.05 | 383.92 | 92.88 | 220.13 | 142.47 | -28.35 |
Other Non Operating Income (Expenses) | 6,088 | -12,757 | 6,091 | 1,215 | -6,451 | -2,839 |
EBT Excluding Unusual Items | -2,113 | -17,955 | -7,696 | -10,108 | -13,674 | -9,430 |
Gain (Loss) on Sale of Investments | -46.34 | - | -2,047 | -1,572 | -619.8 | 1,153 |
Gain (Loss) on Sale of Assets | 27.21 | -96.38 | -211.99 | -7.43 | -108.57 | -196.06 |
Asset Writedown | -143.15 | -142.61 | -1,833 | - | -0.02 | -3,654 |
Other Unusual Items | 830.57 | 1,296 | 11,001 | 351.77 | - | - |
Pretax Income | -1,445 | -16,898 | -786.51 | -11,336 | -14,402 | -12,127 |
Income Tax Expense | 1,099 | 1,035 | -64.76 | 2,037 | -5,876 | -2.06 |
Earnings From Continuing Operations | -2,543 | -17,933 | -721.75 | -13,373 | -8,526 | -12,125 |
Minority Interest in Earnings | -732.54 | -895.34 | -2,228 | 405.12 | 1,710 | -91.98 |
Net Income | -3,276 | -18,828 | -2,950 | -12,968 | -6,817 | -12,217 |
Net Income to Common | -3,276 | -18,828 | -2,950 | -12,968 | -6,817 | -12,217 |
Shares Outstanding (Basic) | 28 | 24 | 23 | 23 | 22 | 22 |
Shares Outstanding (Diluted) | 28 | 24 | 23 | 23 | 22 | 22 |
Shares Change (YoY) | 22.30% | 4.10% | 0.44% | 0.30% | 2.01% | 1.83% |
EPS (Basic) | -116.48 | -800.03 | -130.50 | -576.16 | -303.76 | -555.33 |
EPS (Diluted) | -116.48 | -800.03 | -130.50 | -576.16 | -304.00 | -555.33 |
Free Cash Flow | 2,685 | 2,221 | -6,028 | -8,732 | -11,102 | -16,782 |
Free Cash Flow Per Share | 95.46 | 94.39 | -266.63 | -387.97 | -494.72 | -762.85 |
Gross Margin | 37.90% | 40.36% | 27.14% | 36.74% | 38.00% | 32.28% |
Operating Margin | 1.17% | -5.21% | -35.04% | -22.39% | -14.82% | -25.03% |
Profit Margin | -8.00% | -53.14% | -10.92% | -46.64% | -26.35% | -65.09% |
Free Cash Flow Margin | 6.56% | 6.27% | -22.32% | -31.41% | -42.91% | -89.41% |
EBITDA | 4,851 | 2,640 | -4,824 | -1,782 | -95.46 | -2,457 |
EBITDA Margin | 11.85% | 7.45% | -17.86% | -6.41% | -0.37% | -13.09% |
D&A For EBITDA | 4,372 | 4,487 | 4,640 | 4,442 | 3,739 | 2,241 |
EBIT | 479.33 | -1,846 | -9,464 | -6,224 | -3,834 | -4,698 |
EBIT Margin | 1.17% | -5.21% | -35.04% | -22.39% | -14.82% | -25.03% |
Advertising Expenses | - | 146.49 | 59.82 | 86.97 | 26.09 | 14.25 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.